LISBON, Portugal (AP) — Researchers in the United States and Britain are sharing a 1 million-euro ($1.16 million) prize from a Portuguese scientific foundation for developing revolutionary gene therapy that has restored the sight of children.
The Lisbon, Portugal-based Champalimaud Foundation’s annual Vision Award was given Tuesday for work on the treatment of children blinded from birth by genetic disease.
The foundation says the research brought a medical revolution, paving the way for new treatment of genetic conditions.
The winners are Michael Redmond of the U.S. National Eye Institute, who conducted pioneering early research in the field, and research teams in Pennsylvania, Florida and London, which built on that work.
Most Read Nation & World Stories
- Trump tests presidential power, declares emergency at border WATCH
- Unclaimed $1.5B prize: South Carolina could be big loser too
- High-tech degrees and the price of an avocado: The data New York gave to Amazon
- Hungry bear goes for ride after getting stuck on trash truck
- Year in space put US astronaut's disease defenses on alert